Intravenous immunoglobulin for pembrolizumab-induced bullous pemphigoid-like eruption: A case report [0.03%]
派姆单抗致疱性疾病样皮疹的静脉用免疫球蛋白治疗一例报告
Daichi Hoshina,Moeko Hotta
Daichi Hoshina
Case Reports
Dermatologic therapy. 2022 Dec;35(12):e15948. DOI:10.1111/dth.15948 2022
Fatal low-dose methotrexate toxicity: A case report and literature review [0.03%]
甲氨蝶呤致死性低剂量不良反应的病例报告及文献回顾
Samantha Ouellette,Rohan Shah,Shazli Razi et al.
Samantha Ouellette et al.
Methotrexate (MTX) is a chemotherapeutic agent that acts primarily by inhibiting the folic acid cycle. In addition to its application for treating malignancies, MTX is also used to treat chronic inflammatory diseases including psoriasis. Ad...
Leucocytoclastic vasculitis-like reaction induced by tocilizumab in a patient with rheumatoid arthritis [0.03%]
托珠单抗引起的类白细胞破裂性血管炎样反应1例
Yu-Qing Hu,Xue Chen,Jian-Zhong Zhang
Yu-Qing Hu
Treatment of atopic dermatitis using topical antifungal drugs: A meta-analysis [0.03%]
一项针对特应性皮炎使用外用抗真菌药物治疗的荟萃分析研究
Dan He,Yujie Han,Hongmei Wu et al.
Dan He et al.
Several studies have focused on treating atopic dermatitis (AD) using topical antifungal drugs. However, their findings are inconsistent. This meta-analysis of randomized controlled trials (RCTs) aimed to evaluate the safety and efficacy of...
Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial [0.03%]
拉坦前列腺素与米诺地尔、倍他米松及联合治疗斑秃疗效、安全性和患者顺应性的比较：一项盲法多组随机对照试验
Mohammadreza Ghassemi,Nafise Yazdanian,Elham Behrangi et al.
Mohammadreza Ghassemi et al.
Alopecia areata (AA), a polygenic and chronic autoimmune disease and there is no definitive cure. We aimed to evaluate latanoprost effects in patients with AA. In this controlled randomized double-blind clinical trial, we enrolled patients ...
Randomized Controlled Trial
Dermatologic therapy. 2022 Dec;35(12):e15943. DOI:10.1111/dth.15943 2022
Bullous lichen sclerosus-generalized morphea overlap syndrome improved by tofacitinib [0.03%]
托法替布治疗硬化性萎缩性苔藓-硬斑病重叠综合征获得良好疗效
Licong Liu,Yi Zhan,Yaqian Shi et al.
Licong Liu et al.
We here report a case of a middle-aged man with an unusual case of bullous lichen sclerosus complicated with generalized morphea. He showed initial recurrent flaccid bullae, followed by ivory-white sclerotic plaques and extensive skin scler...
Case Reports
Dermatologic therapy. 2022 Dec;35(12):e15942. DOI:10.1111/dth.15942 2022
Alopecia areata induced by Adalimumab in a patient with Crohn's disease [0.03%]
克罗恩病患者使用阿达木单抗诱发斑片状脱发1例报告
Gianluca Esposito,Serena Spennato,Luigi Guerriero et al.
Gianluca Esposito et al.
Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real-life study [0.03%]
特立德珠单抗治疗中至重度银屑病的初步真实世界研究结果：单中心研究
Angelo Ruggiero,Luca Potestio,Sara Cacciapuoti et al.
Angelo Ruggiero et al.
Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child [0.03%]
乌司奴单抗成功治疗一名巴西儿童CARD14相关性皮疹鳞屑性疾病
Ana Elisa Kiszewski,Hiram Larangeira De Almeida Jr
Ana Elisa Kiszewski
CARD14-associated papulosquamous eruption (CAPE) was proposed in 2018 to describe the clinical features of psoriasis and pityriasis rubra pilaris with CARD 14 mutations. We report a 5-month-old female infant who developed CAPE-associated er...
Case Reports
Dermatologic therapy. 2022 Dec;35(12):e15939. DOI:10.1111/dth.15939 2022
Adriana Di Guida,Patrizia Forgione,Luigi Fornaro et al.
Adriana Di Guida et al.